Correction to Lancet Infect Dis 2020; 20: 661

Ektorp E. Death threats after a trial on chloroquine for COVID-19. Lancet Infect Dis 2020; 20: 661—In this Newsdesk piece, the final sentence of the first paragraph should read “The study involved 21 research institutions in Brazil, Spain, and Mozambique, with participants recruited from one site in Brazil, and was initially available…” And in the second paragraph, the second sentence should read “While 41 patients received a high dose of 600 mg of CQ twice daily for 10 days, the other group of 40 patients received a lower dose of 450 mg twice daily on day 1 and then once daily for 4 days.” And the fourth sentence should read “As of April 5, 2020, approximately 2 weeks after study start, 11 patients has died, seven in the high-dose group and four in the low-dose group.”. These corrections have been made to the online version as of June 4, 2020.